Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animal Drug User Fee Cover Sheet, FDA Form 3546, 65341-65342 [E7-22649]

Download as PDF Federal Register / Vol. 72, No. 223 / Tuesday, November 20, 2007 / Notices GENERAL SERVICES ADMINISTRATION [OMB Control No. 3090–0221] Civilian Board of Contract Appeals; Information Collection; Civilian Board of Contract Appeals Rules of Procedure Civilian Board of Contract Appeals, GSA. ACTION: Notice of request for comments regarding a revision to an existing OMB clearance. AGENCY: Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the General Services Administration will be submitting to the Office of Management and Budget (OMB) a request to review and approve an extension of a currently approved information collection requirement regarding the Civilian Board of Contract Appeals (CBCA) Rules of Procedure. The clearance currently expires on January 31, 2008. Public comments are particularly invited on: Whether this collection of information is necessary and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate and based on valid assumptions and methodology; and ways to enhance the quality, utility, and clarity of the information to be collected. DATES: Submit comments on or before: January 22, 2008. FOR FURTHER INFORMATION CONTACT: Margaret S. Pfunder, Chief Counsel, Civilian Board of Contract Appeals, 1800 F Street, NW., Washington, DC 20405, telephone (202) 606–8800 or via e-mail to Margaret.Pfunder@gsa.gov. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to the Regulatory Secretariat (VIR), General Services Administration, Room 4035, 1800 F Street, NW., Washington, DC 20405. Please cite OMB Control No. 3090–0221, Civilian Board of Contract Appeals Rules Procedure, in all correspondence. SUPPLEMENTARY INFORMATION: pwalker on PROD1PC71 with NOTICES SUMMARY: A. Purpose The CBCA requires the information collected in order to conduct proceedings in contract appeals and petitions, and cost applications. Parties include those persons or entities filing appeals, petitions, cost applications, and government agencies. B. Annual Reporting Burden Respondents: 55. VerDate Aug<31>2005 17:01 Nov 19, 2007 Jkt 214001 Responses Per Respondent: 1. Hours Per Response: .117. Total Burden Hours: 6.4. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VIR), 1800 F Street, NW., Room 4035, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 3090–0221, Civilian Board of Contract Appeals Rules of Procedure, in all correspondence. Dated: October 30, 2007 Casey Coleman, Chief Information Officer. [FR Doc. E7–22603 Filed 11–19–07; 8:45 am] BILLING CODE 6820–AL–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Blood Safety and Availability Department of Health and Human Services, Office of the Secretary. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood Safety and Availability (ACBSA) will hold a meeting. The meeting will be open to the public. DATES: The meeting will take place Wednesday, January 9, 2008 and Thursday, January 10, 2008 from 9 a.m. to 5 p.m. ADDRESSES: The Westin Washington, DC City Center, 1400 M Street, NW., Washington, DC 20005. Phone: (202) 429–1700. FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive Secretary, Advisory Committee on Blood Safety and Availability, Office of Public Health and Science, Department of Health and Human Services, 1101 Wootton Parkway, Room 250, Rockville, MD 20852, (240) 453–8803, Fax (240) 453– 8456, e-mail ACBSA@hhs.gov. SUPPLEMENTARY INFORMATION: Since the early 1980s there has been a heightened awareness of transfusion and transplantation safety. The formation of the ACBSA directly resulted out of concern regarding infectious diseases and the safety of the blood supply. At this session of the ACBSA, the Committee will discuss further safety developments to enhance transfusion and transplantation safety. These discussions will include the current 65341 landscape and residual risk of known and unknown pathogens. In addition, the Committee will look at needs and barriers to potential opportunities in donor screening and technologies for pathogen reduction. The public will be given opportunity to provide comments to the Committee on January 9 and 10, 2008. Comments will be limited to five minutes per speaker. Anyone planning to comment is encouraged to contact the Executive Secretary at his/her earliest convenience. Those who wish to have printed material distributed to Advisory Committee members should submit, at a minimum, one copy of the material, to the Executive Secretary prior to close of business January 7, 2008. Likewise, those who wish to utilize electronic data projection to the Committee must submit their materials to the Executive Secretary prior to close of business January 7, 2008. Dated: November 13, 2007. Jerry A. Holmberg, Executive Secretary, Advisory Committee on Blood Safety and Availability. [FR Doc. E7–22653 Filed 11–19–07; 8:45 am] BILLING CODE 4150–41–P SUMMARY: PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007N–0220] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animal Drug User Fee Cover Sheet, FDA Form 3546 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by December 20, 2007. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–6974, or e-mailed to baguilar@omb.eop.gov. All comments should be identified with the OMB control number 0910–0539. Also E:\FR\FM\20NON1.SGM 20NON1 65342 Federal Register / Vol. 72, No. 223 / Tuesday, November 20, 2007 / Notices 12), FDA has the authority to assess and collect for certain animal drug user fees. Because the submission of user fees concurrently with applications and supplements is required, review of an application cannot begin until the fee is submitted. The types of fees that require a cover sheet, are certain animal drug application fees and certain supplemental animal drug application fees. The cover sheet FDA Form 3546, is designed to provide the minimum necessary information to determine whether a fee is required for the review of an application or supplement, to determine the amount of the fee required, and to assure that each animal drug user fee payment and each animal drug application for which payment is made, is appropriately linked to that payment. The form, when completed include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley Jr. Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827– 1472. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Animal Drug User Fee Cover Sheet; FDA Form 3546; 21 U.S.C. 379j–12; (OMB Control Number: 0910–0539)— Extension Under Section 740 of the act, as amended by ADUFA (21 U.S.C. 379j– electronically, will result in the generation of a unique payment identification number used for tracking the payment. FDA will use the information collected to initiate administrative screening of new animal drug applications and supplements to determine if payment has been received. In a Federal Register of June 15, 2007 (72 FR 33231), FDA published a 60-day notice soliciting public comment on the proposed collection of information provisions. In response to that notice, no comments were received. Respondents to this collection of information are new animal drug sponsors applicants or manufacturers. FDA estimates the burden of this collection of information as follows: TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1 Number of Respondents 21 U.S.C. 379j–12 740(a)(1) FDA Form 3546 (Cover Sheet) 1 There Annual Frequency per Response 69 Total annual Responses 1 time for each application Hours per Response 69 Total Hours 1 69 are no capital costs or operating and maintenance costs associated with this collection of information. Dated: November 14, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–22649 Filed 11–19–07; 8:45 am] Compliance Branch, Tel. (202) 863– 6543. SUPPLEMENTARY INFORMATION: Background BILLING CODE 4160–01–S Dated: November 15, 2007. Daniel Baldwin, Assistant Commissioner, Office of International Trade. [FR Doc. E7–22646 Filed 11–19–07; 8:45 am] BILLING CODE 9111–14–P DEPARTMENT OF HOMELAND SECURITY Bureau of Customs and Border Protection FBI Fingerprint Fee Bureau of Customs and Border Protection, U.S. Department of Homeland Security. ACTION: General notice. pwalker on PROD1PC71 with NOTICES AGENCY: SUMMARY: This document announces that the fee collected by Customs and Border Protection regarding the submission of fingerprints for those applying for certain positions or requesting various identification cards which necessitate a fingerprint records check, will be raised to a total of $32.49 to offset the fee being charged Customs and Border Protection by the Federal Bureau of Investigation. EFFECTIVE DATES: November 20, 2007. FOR FURTHER INFORMATION CONTACT: Customs and Border Protection, Office of International Trade, Broker VerDate Aug<31>2005 17:01 Nov 19, 2007 Jkt 214001 The Federal Bureau of Investigation (FBI) is authorized to charge a fee for processing fingerprint identification records for non-law enforcement employment and licensing purposes. See Note to 28 U.S.C. 534. Customs and Border Protection (CBP) has traditionally used the FBI fingerprinting services. The Customs Regulations were amended by T.D. 93– 18 (58 FR 15770, dated March 24, 1993) to provide that CBP will charge a fee to recover the FBI fingerprinting costs, plus an additional 15% of that amount to cover CBP administrative processing. The authority for CBP to assess such a fee is 31 U.S.C. 9701. The port director advises those required to submit the fee of the correct amount. The current user fee charged by the FBI is $28.25. Accordingly, in this document, notice is hereby given that the fee charged by CBP will be raised to a total of $32.49: $28.25 representing the FBI portion of the fee, and $4.24 representing the 15% CBP charges to cover administrative processing. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5117–N–97] Notice of Submission of Proposed Information Collection to OMB; Housing Discrimination Information Form (HUD–903.1) Office of the Chief Information Officer, HUD ACTION: Notice. AGENCY: SUMMARY: The proposed information collection requirement described below has been submitted to the Office of Management and Budget (OMB) for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments on the subject proposal. This information collection is necessary to establish HUD’s jurisdiction to investigate housing discrimination complaints filed under the Fair Housing Act. The information is used to contact the aggrieved person, and to assess the complaint allegations. E:\FR\FM\20NON1.SGM 20NON1

Agencies

[Federal Register Volume 72, Number 223 (Tuesday, November 20, 2007)]
[Notices]
[Pages 65341-65342]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-22649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2007N-0220]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Animal Drug User Fee 
Cover Sheet, FDA Form 3546

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by 
December 20, 2007.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be faxed to the Office 
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, 
FAX: 202-395-6974, or e-mailed to baguilar@omb.eop.gov. All comments 
should be identified with the OMB control number 0910-0539. Also

[[Page 65342]]

include the FDA docket number found in brackets in the heading of this 
document.

FOR FURTHER INFORMATION CONTACT: Denver Presley Jr. Office of the Chief 
Information Officer (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-1472.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Animal Drug User Fee Cover Sheet; FDA Form 3546; 21 U.S.C. 379j-12; 
(OMB Control Number: 0910-0539)--Extension

    Under Section 740 of the act, as amended by ADUFA (21 U.S.C. 379j-
12), FDA has the authority to assess and collect for certain animal 
drug user fees. Because the submission of user fees concurrently with 
applications and supplements is required, review of an application 
cannot begin until the fee is submitted. The types of fees that require 
a cover sheet, are certain animal drug application fees and certain 
supplemental animal drug application fees. The cover sheet FDA Form 
3546, is designed to provide the minimum necessary information to 
determine whether a fee is required for the review of an application or 
supplement, to determine the amount of the fee required, and to assure 
that each animal drug user fee payment and each animal drug application 
for which payment is made, is appropriately linked to that payment. The 
form, when completed electronically, will result in the generation of a 
unique payment identification number used for tracking the payment. FDA 
will use the information collected to initiate administrative screening 
of new animal drug applications and supplements to determine if payment 
has been received.
    In a Federal Register of June 15, 2007 (72 FR 33231), FDA published 
a 60-day notice soliciting public comment on the proposed collection of 
information provisions. In response to that notice, no comments were 
received.
    Respondents to this collection of information are new animal drug 
sponsors applicants or manufacturers.
    FDA estimates the burden of this collection of information as 
follows:

                                 Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
                       Number of       Annual Frequency     Total annual        Hours per
21 U.S.C. 379j-12     Respondents        per Response        Responses           Response         Total Hours
----------------------------------------------------------------------------------------------------------------
740(a)(1)                         69    1 time for each                 69                  1                 69
FDA Form 3546                               application
 (Cover Sheet)
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.


    Dated: November 14, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-22649 Filed 11-19-07; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.